Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 4.76541628 |
2 | nucleobase biosynthetic process (GO:0046112) | 4.71409872 |
3 | purine nucleobase biosynthetic process (GO:0009113) | 4.61622247 |
4 | maturation of SSU-rRNA (GO:0030490) | 4.50803287 |
5 | DNA deamination (GO:0045006) | 4.50281985 |
6 | formation of translation preinitiation complex (GO:0001731) | 4.43447265 |
7 | viral transcription (GO:0019083) | 4.41544978 |
8 | GDP-mannose metabolic process (GO:0019673) | 4.34617018 |
9 | translational termination (GO:0006415) | 4.33582315 |
10 | folic acid metabolic process (GO:0046655) | 4.30068229 |
11 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.28762917 |
12 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.26998348 |
13 | protein maturation by protein folding (GO:0022417) | 4.25988040 |
14 | ribosomal small subunit biogenesis (GO:0042274) | 4.14500514 |
15 | DNA strand elongation (GO:0022616) | 4.05812098 |
16 | glycine metabolic process (GO:0006544) | 4.04615147 |
17 | translational elongation (GO:0006414) | 4.02370837 |
18 | ribosome assembly (GO:0042255) | 4.00927146 |
19 | DNA replication initiation (GO:0006270) | 3.92853781 |
20 | regulation of cholesterol esterification (GO:0010872) | 3.92624599 |
21 | translational initiation (GO:0006413) | 3.91753909 |
22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.91685795 |
23 | L-phenylalanine metabolic process (GO:0006558) | 3.91685795 |
24 | DNA unwinding involved in DNA replication (GO:0006268) | 3.90809232 |
25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.90572821 |
26 | ribosomal large subunit biogenesis (GO:0042273) | 3.90037332 |
27 | L-serine metabolic process (GO:0006563) | 3.76191516 |
28 | proline biosynthetic process (GO:0006561) | 3.72448728 |
29 | serine family amino acid biosynthetic process (GO:0009070) | 3.71056512 |
30 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.70525026 |
31 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.66505234 |
32 | ribosome biogenesis (GO:0042254) | 3.58123623 |
33 | phospholipid efflux (GO:0033700) | 3.56088145 |
34 | proteasome assembly (GO:0043248) | 3.55599141 |
35 | protein targeting to ER (GO:0045047) | 3.55362268 |
36 | cotranslational protein targeting to membrane (GO:0006613) | 3.54525041 |
37 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.54161420 |
38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.52123062 |
39 | pentose metabolic process (GO:0019321) | 3.49507544 |
40 | regulation of mitochondrial translation (GO:0070129) | 3.46311007 |
41 | pinocytosis (GO:0006907) | 3.43075565 |
42 | proline metabolic process (GO:0006560) | 3.42254256 |
43 | IMP biosynthetic process (GO:0006188) | 3.41259830 |
44 | protein localization to kinetochore (GO:0034501) | 3.41120487 |
45 | L-phenylalanine catabolic process (GO:0006559) | 3.41078943 |
46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.41078943 |
47 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.38769885 |
48 | protein localization to endoplasmic reticulum (GO:0070972) | 3.37354079 |
49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37319167 |
50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37319167 |
51 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.35612049 |
52 | cellular protein complex disassembly (GO:0043624) | 3.34415883 |
53 | viral life cycle (GO:0019058) | 3.33165572 |
54 | telomere maintenance via recombination (GO:0000722) | 3.32797501 |
55 | DNA replication checkpoint (GO:0000076) | 3.31811423 |
56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23430785 |
57 | protein carboxylation (GO:0018214) | 3.23430785 |
58 | mitotic nuclear envelope disassembly (GO:0007077) | 3.21277773 |
59 | rRNA processing (GO:0006364) | 3.19806187 |
60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.17656458 |
61 | mitotic metaphase plate congression (GO:0007080) | 3.16597312 |
62 | folic acid-containing compound metabolic process (GO:0006760) | 3.13183583 |
63 | translation (GO:0006412) | 3.12615550 |
64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.12602368 |
65 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.12261934 |
66 | tetrahydrofolate metabolic process (GO:0046653) | 3.11571170 |
67 | telomere maintenance via telomere lengthening (GO:0010833) | 3.11096987 |
68 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.10101496 |
69 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.10101496 |
70 | mitotic recombination (GO:0006312) | 3.10000152 |
71 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.09855551 |
72 | pseudouridine synthesis (GO:0001522) | 3.08314647 |
73 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.07617389 |
74 | rRNA metabolic process (GO:0016072) | 3.07487577 |
75 | spliceosomal snRNP assembly (GO:0000387) | 3.07299784 |
76 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.06664915 |
77 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.06365999 |
78 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.04113867 |
79 | protein complex disassembly (GO:0043241) | 3.02083365 |
80 | IMP metabolic process (GO:0046040) | 3.01864646 |
81 | serine family amino acid metabolic process (GO:0009069) | 3.00101785 |
82 | regulation of lipoprotein particle clearance (GO:0010984) | 2.98470283 |
83 | deoxyribonucleotide catabolic process (GO:0009264) | 2.95916367 |
84 | pentose-phosphate shunt (GO:0006098) | 2.92004620 |
85 | nuclear envelope disassembly (GO:0051081) | 2.91992359 |
86 | membrane disassembly (GO:0030397) | 2.91992359 |
87 | deoxyribose phosphate catabolic process (GO:0046386) | 2.90580642 |
88 | negative regulation of ligase activity (GO:0051352) | 2.90524901 |
89 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.90524901 |
90 | L-methionine biosynthetic process (GO:0071265) | 2.90182875 |
91 | amino acid salvage (GO:0043102) | 2.90182875 |
92 | L-methionine salvage (GO:0071267) | 2.90182875 |
93 | negative regulation of fibrinolysis (GO:0051918) | 2.89383591 |
94 | base-excision repair, AP site formation (GO:0006285) | 2.89106730 |
95 | iron-sulfur cluster assembly (GO:0016226) | 2.86550471 |
96 | metallo-sulfur cluster assembly (GO:0031163) | 2.86550471 |
97 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.85471339 |
98 | macromolecular complex disassembly (GO:0032984) | 2.85401504 |
99 | protein localization to chromosome, centromeric region (GO:0071459) | 2.84164401 |
100 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.82356707 |
101 | nucleoside salvage (GO:0043174) | 2.81811114 |
102 | pteridine-containing compound metabolic process (GO:0042558) | 2.76126749 |
103 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.74021668 |
104 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.73165931 |
105 | plasma lipoprotein particle assembly (GO:0034377) | 2.73112344 |
106 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72429283 |
107 | urea metabolic process (GO:0019627) | 2.72035455 |
108 | cellular component biogenesis (GO:0044085) | 2.72018458 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.71828728 |
110 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.71596143 |
111 | rRNA modification (GO:0000154) | 2.71268074 |
112 | CENP-A containing nucleosome assembly (GO:0034080) | 2.71245149 |
113 | urea cycle (GO:0000050) | 2.68819300 |
114 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.68778050 |
115 | chromatin remodeling at centromere (GO:0031055) | 2.68672630 |
116 | regulation of fibrinolysis (GO:0051917) | 2.68153647 |
117 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.67859303 |
118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.67451878 |
119 | negative regulation of B cell apoptotic process (GO:0002903) | 2.67202816 |
120 | COPI coating of Golgi vesicle (GO:0048205) | 2.67030718 |
121 | Golgi transport vesicle coating (GO:0048200) | 2.67030718 |
122 | cell cycle G1/S phase transition (GO:0044843) | 2.66956927 |
123 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.66956927 |
124 | 4-hydroxyproline metabolic process (GO:0019471) | 2.66790268 |
125 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.66716041 |
126 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.66514386 |
127 | nitrogen cycle metabolic process (GO:0071941) | 2.66324679 |
128 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.66244273 |
129 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66236949 |
130 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65790893 |
131 | sulfur amino acid biosynthetic process (GO:0000097) | 2.65646691 |
132 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.65018949 |
133 | regulation of translational termination (GO:0006449) | 2.64606655 |
134 | UTP biosynthetic process (GO:0006228) | 2.64322784 |
135 | regulation of spindle organization (GO:0090224) | 2.63819732 |
136 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.63303320 |
137 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.63303320 |
138 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.61554935 |
139 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61554935 |
140 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.61554935 |
141 | negative regulation of sterol transport (GO:0032372) | 2.61429534 |
142 | negative regulation of cholesterol transport (GO:0032375) | 2.61429534 |
143 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61289372 |
144 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61289372 |
145 | methionine biosynthetic process (GO:0009086) | 2.61282062 |
146 | pyrimidine-containing compound salvage (GO:0008655) | 2.61192372 |
147 | pyrimidine nucleoside salvage (GO:0043097) | 2.61192372 |
148 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.61185259 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60383959 |
150 | glucose catabolic process (GO:0006007) | 2.60139193 |
151 | NIK/NF-kappaB signaling (GO:0038061) | 2.60118904 |
152 | glyoxylate metabolic process (GO:0046487) | 2.60050613 |
153 | histone arginine methylation (GO:0034969) | 2.59919579 |
154 | folic acid transport (GO:0015884) | 2.59570661 |
155 | chaperone-mediated protein complex assembly (GO:0051131) | 2.58803093 |
156 | RNA catabolic process (GO:0006401) | 2.58260134 |
157 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.56376228 |
158 | NADPH regeneration (GO:0006740) | 2.54770508 |
159 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.53032593 |
160 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.53032593 |
161 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52975018 |
162 | UV protection (GO:0009650) | 2.52762006 |
163 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.52667895 |
164 | GTP biosynthetic process (GO:0006183) | 2.51846222 |
165 | protein retention in ER lumen (GO:0006621) | 2.49328121 |
166 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.47642591 |
167 | cholesterol efflux (GO:0033344) | 2.47620078 |
168 | sulfur amino acid catabolic process (GO:0000098) | 2.46107899 |
169 | protein-lipid complex assembly (GO:0065005) | 2.45688989 |
170 | amyloid precursor protein catabolic process (GO:0042987) | 2.45569218 |
171 | oxidative phosphorylation (GO:0006119) | 2.43231857 |
172 | purine ribonucleotide transport (GO:0015868) | 2.42297032 |
173 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.42203159 |
174 | rRNA transcription (GO:0009303) | 2.40797648 |
175 | nucleotide salvage (GO:0043173) | 2.40755717 |
176 | UTP metabolic process (GO:0046051) | 2.39375243 |
177 | regulation of triglyceride catabolic process (GO:0010896) | 2.38548128 |
178 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.38516316 |
179 | fibrinolysis (GO:0042730) | 2.38445427 |
180 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.37914020 |
181 | GMP metabolic process (GO:0046037) | 2.36440077 |
182 | regulation of superoxide anion generation (GO:0032928) | 2.34396898 |
183 | protein-lipid complex remodeling (GO:0034368) | 2.34169112 |
184 | macromolecular complex remodeling (GO:0034367) | 2.34169112 |
185 | plasma lipoprotein particle remodeling (GO:0034369) | 2.34169112 |
186 | peptidyl-arginine N-methylation (GO:0035246) | 2.32955107 |
187 | peptidyl-arginine methylation (GO:0018216) | 2.32955107 |
188 | monosaccharide biosynthetic process (GO:0046364) | 2.32713642 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.25888488 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.16079072 |
3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04917679 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94931492 |
5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.91105184 |
6 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.86172642 |
7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72052445 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.71464824 |
9 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69989408 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69456527 |
11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.63394301 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59509933 |
13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.52551910 |
14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.51797222 |
15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47522034 |
16 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.29645289 |
17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.27829433 |
18 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19163541 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14514012 |
20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05045965 |
21 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03457058 |
22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.99894110 |
23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93262109 |
24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.90451623 |
25 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.90110300 |
26 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89001366 |
27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83402846 |
28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83170848 |
29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.80771029 |
30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80580362 |
31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73550732 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72098505 |
33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72025357 |
34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72013089 |
35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68107865 |
36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67228470 |
37 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66851603 |
38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61403431 |
39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59037914 |
40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.57679561 |
41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57599968 |
42 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57492527 |
43 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57461198 |
44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56920726 |
45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56574483 |
46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56361774 |
47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54138776 |
48 | * MYC_22102868_ChIP-Seq_BL_Human | 1.53746271 |
49 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53263929 |
50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51240913 |
51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47985665 |
52 | * P68_20966046_ChIP-Seq_HELA_Human | 1.47728423 |
53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47580704 |
54 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47416652 |
55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45893086 |
56 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.44989028 |
57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43967760 |
58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42417962 |
59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42130361 |
60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41159424 |
61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39544995 |
62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37987595 |
63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37863220 |
64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37838676 |
65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35621936 |
66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34365554 |
67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34236308 |
68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33197750 |
69 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.30857240 |
70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28802255 |
71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28321645 |
72 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28088229 |
73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28058033 |
74 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.27890865 |
75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27218241 |
76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24413263 |
77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23919738 |
78 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.23188910 |
79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23014822 |
80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22601373 |
81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21510501 |
82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21298372 |
83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20762288 |
84 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20155128 |
85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19803358 |
86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.19236263 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18867603 |
88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18860636 |
89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18326320 |
90 | MAF_26560356_Chip-Seq_TH2_Human | 1.18282151 |
91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18256487 |
92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17806958 |
93 | MAF_26560356_Chip-Seq_TH1_Human | 1.17690971 |
94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16922610 |
95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16694775 |
96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15194059 |
97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11924306 |
98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11473366 |
99 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10308717 |
100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09932851 |
101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09763015 |
102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09713854 |
103 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09281616 |
104 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.09111940 |
105 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08901622 |
106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08779109 |
107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08058507 |
108 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07643345 |
109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07419420 |
110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06000575 |
111 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.05985442 |
112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05170300 |
113 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04989051 |
114 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03977356 |
115 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02898045 |
116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02396507 |
117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01964475 |
118 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01850974 |
119 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.01790025 |
120 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01488894 |
121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01283406 |
122 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01129672 |
123 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00418399 |
124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97702303 |
125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96958631 |
126 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96797740 |
127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96439349 |
128 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94864900 |
129 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93233986 |
130 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92165020 |
131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91870713 |
132 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.91350687 |
133 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89159999 |
134 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88958231 |
135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88515577 |
136 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85525213 |
137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83470710 |
138 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81958028 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.62055497 |
2 | MP0004957_abnormal_blastocyst_morpholog | 3.76711830 |
3 | MP0005058_abnormal_lysosome_morphology | 3.64211661 |
4 | MP0003111_abnormal_nucleus_morphology | 3.51329576 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.25765525 |
6 | MP0009840_abnormal_foam_cell | 3.10664474 |
7 | MP0010094_abnormal_chromosome_stability | 3.04523169 |
8 | MP0008260_abnormal_autophagy | 3.04271824 |
9 | MP0003077_abnormal_cell_cycle | 2.99931200 |
10 | MP0002877_abnormal_melanocyte_morpholog | 2.71652899 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.50834140 |
12 | MP0005360_urolithiasis | 2.32086604 |
13 | MP0010352_gastrointestinal_tract_polyps | 2.16496637 |
14 | MP0008932_abnormal_embryonic_tissue | 2.11020848 |
15 | MP0003123_paternal_imprinting | 2.10291237 |
16 | MP0001730_embryonic_growth_arrest | 2.09975451 |
17 | MP0003436_decreased_susceptibility_to | 2.07929341 |
18 | MP0008057_abnormal_DNA_replication | 2.07524383 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.00864127 |
20 | MP0008058_abnormal_DNA_repair | 1.98302262 |
21 | MP0009278_abnormal_bone_marrow | 1.96303413 |
22 | MP0008007_abnormal_cellular_replicative | 1.93530758 |
23 | MP0005365_abnormal_bile_salt | 1.91846029 |
24 | MP0005464_abnormal_platelet_physiology | 1.79879419 |
25 | MP0005085_abnormal_gallbladder_physiolo | 1.77899750 |
26 | MP0002396_abnormal_hematopoietic_system | 1.77214641 |
27 | MP0001835_abnormal_antigen_presentation | 1.76480434 |
28 | MP0003718_maternal_effect | 1.71911751 |
29 | MP0003567_abnormal_fetal_cardiomyocyte | 1.68804969 |
30 | MP0003186_abnormal_redox_activity | 1.65564902 |
31 | MP0005025_abnormal_response_to | 1.64676350 |
32 | MP0000350_abnormal_cell_proliferation | 1.64632603 |
33 | MP0001672_abnormal_embryogenesis/_devel | 1.55650893 |
34 | MP0005380_embryogenesis_phenotype | 1.55650893 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.54971211 |
36 | MP0002419_abnormal_innate_immunity | 1.53077854 |
37 | MP0001697_abnormal_embryo_size | 1.52059868 |
38 | MP0003172_abnormal_lysosome_physiology | 1.49124489 |
39 | MP0000490_abnormal_crypts_of | 1.49048745 |
40 | MP0000685_abnormal_immune_system | 1.48718711 |
41 | MP0003303_peritoneal_inflammation | 1.47308500 |
42 | MP0002080_prenatal_lethality | 1.45789421 |
43 | MP0003984_embryonic_growth_retardation | 1.45023073 |
44 | MP0002088_abnormal_embryonic_growth/wei | 1.43889466 |
45 | MP0000372_irregular_coat_pigmentation | 1.40285536 |
46 | MP0003786_premature_aging | 1.39576056 |
47 | MP0005083_abnormal_biliary_tract | 1.36979463 |
48 | MP0010030_abnormal_orbit_morphology | 1.33646689 |
49 | MP0002086_abnormal_extraembryonic_tissu | 1.33265979 |
50 | MP0002148_abnormal_hypersensitivity_rea | 1.31640589 |
51 | MP0008469_abnormal_protein_level | 1.31272640 |
52 | MP0010307_abnormal_tumor_latency | 1.30522023 |
53 | MP0009785_altered_susceptibility_to | 1.29385613 |
54 | MP0002723_abnormal_immune_serum | 1.27874137 |
55 | MP0009333_abnormal_splenocyte_physiolog | 1.27658126 |
56 | MP0000678_abnormal_parathyroid_gland | 1.26780993 |
57 | MP0004197_abnormal_fetal_growth/weight/ | 1.26345383 |
58 | MP0004858_abnormal_nervous_system | 1.25963475 |
59 | MP0005023_abnormal_wound_healing | 1.25897745 |
60 | MP0005000_abnormal_immune_tolerance | 1.25347579 |
61 | MP0005332_abnormal_amino_acid | 1.25097021 |
62 | MP0005671_abnormal_response_to | 1.22868847 |
63 | MP0009053_abnormal_anal_canal | 1.21720530 |
64 | MP0001800_abnormal_humoral_immune | 1.21295183 |
65 | MP0002019_abnormal_tumor_incidence | 1.20122079 |
66 | MP0002452_abnormal_antigen_presenting | 1.18645767 |
67 | MP0001819_abnormal_immune_cell | 1.18295532 |
68 | MP0002420_abnormal_adaptive_immunity | 1.17823602 |
69 | MP0002085_abnormal_embryonic_tissue | 1.17302488 |
70 | MP0000313_abnormal_cell_death | 1.15613155 |
71 | MP0003195_calcinosis | 1.15600275 |
72 | MP0000015_abnormal_ear_pigmentation | 1.15283802 |
73 | MP0000358_abnormal_cell_content/ | 1.13653637 |
74 | MP0010329_abnormal_lipoprotein_level | 1.13544652 |
75 | MP0004381_abnormal_hair_follicle | 1.12001112 |
76 | MP0000598_abnormal_liver_morphology | 1.10890214 |
77 | MP0005451_abnormal_body_composition | 1.10333124 |
78 | MP0002084_abnormal_developmental_patter | 1.09607482 |
79 | MP0003075_altered_response_to | 1.08549018 |
80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07036710 |
81 | MP0000537_abnormal_urethra_morphology | 1.05484629 |
82 | MP0000716_abnormal_immune_system | 1.04557409 |
83 | MP0003763_abnormal_thymus_physiology | 1.04509360 |
84 | MP0001666_abnormal_nutrient_absorption | 1.04383645 |
85 | MP0005387_immune_system_phenotype | 1.03912552 |
86 | MP0001790_abnormal_immune_system | 1.03912552 |
87 | MP0003191_abnormal_cellular_cholesterol | 1.03639098 |
88 | MP0001845_abnormal_inflammatory_respons | 1.01704348 |
89 | MP0004019_abnormal_vitamin_homeostasis | 1.01560743 |
90 | MP0000681_abnormal_thyroid_gland | 0.99829662 |
91 | MP0000343_altered_response_to | 0.98734326 |
92 | MP0009672_abnormal_birth_weight | 0.97925348 |
93 | MP0003119_abnormal_digestive_system | 0.97839076 |
94 | MP0000609_abnormal_liver_physiology | 0.97838014 |
95 | MP0005319_abnormal_enzyme/_coenzyme | 0.97623784 |
96 | MP0002132_abnormal_respiratory_system | 0.97512180 |
97 | MP0004808_abnormal_hematopoietic_stem | 0.97172181 |
98 | MP0001661_extended_life_span | 0.95505400 |
99 | MP0005397_hematopoietic_system_phenotyp | 0.95348274 |
100 | MP0001545_abnormal_hematopoietic_system | 0.95348274 |
101 | MP0004185_abnormal_adipocyte_glucose | 0.94089731 |
102 | MP0003315_abnormal_perineum_morphology | 0.93274516 |
103 | MP0001293_anophthalmia | 0.91968382 |
104 | MP0006082_CNS_inflammation | 0.90041111 |
105 | MP0004264_abnormal_extraembryonic_tissu | 0.89774186 |
106 | MP0001915_intracranial_hemorrhage | 0.89190109 |
107 | MP0006036_abnormal_mitochondrial_physio | 0.88875173 |
108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88671943 |
109 | MP0001533_abnormal_skeleton_physiology | 0.88357811 |
110 | MP0003566_abnormal_cell_adhesion | 0.87584062 |
111 | MP0005501_abnormal_skin_physiology | 0.86409583 |
112 | MP0005330_cardiomyopathy | 0.86036579 |
113 | MP0006054_spinal_hemorrhage | 0.85479707 |
114 | MP0009764_decreased_sensitivity_to | 0.84809294 |
115 | MP0005075_abnormal_melanosome_morpholog | 0.84658016 |
116 | MP0002249_abnormal_larynx_morphology | 0.83755770 |
117 | MP0006035_abnormal_mitochondrial_morpho | 0.83001982 |
118 | MP0002722_abnormal_immune_system | 0.82010558 |
119 | MP0005670_abnormal_white_adipose | 0.81847120 |
120 | MP0010155_abnormal_intestine_physiology | 0.80705003 |
121 | MP0002111_abnormal_tail_morphology | 0.80484160 |
122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80341532 |
123 | MP0005171_absent_coat_pigmentation | 0.80296437 |
124 | MP0000858_altered_metastatic_potential | 0.80122973 |
125 | MP0002405_respiratory_system_inflammati | 0.79808681 |
126 | MP0000689_abnormal_spleen_morphology | 0.78941100 |
127 | MP0005165_increased_susceptibility_to | 0.78316706 |
128 | MP0001873_stomach_inflammation | 0.77719722 |
129 | MP0009697_abnormal_copulation | 0.77009549 |
130 | MP0000477_abnormal_intestine_morphology | 0.75413267 |
131 | MP0009643_abnormal_urine_homeostasis | 0.74674395 |
132 | MP0005408_hypopigmentation | 0.74481282 |
133 | MP0001849_ear_inflammation | 0.74095547 |
134 | MP0002160_abnormal_reproductive_system | 0.73554667 |
135 | MP0001853_heart_inflammation | 0.72646568 |
136 | MP0000703_abnormal_thymus_morphology | 0.69309121 |
137 | * MP0001764_abnormal_homeostasis | 0.67728190 |
138 | MP0009379_abnormal_foot_pigmentation | 0.67364315 |
139 | MP0005389_reproductive_system_phenotype | 0.67166715 |
140 | MP0005395_other_phenotype | 0.66761394 |
141 | MP0001145_abnormal_male_reproductive | 0.66227023 |
142 | MP0002092_abnormal_eye_morphology | 0.64627116 |
143 | MP0005384_cellular_phenotype | 0.64055726 |
144 | MP0004133_heterotaxia | 0.63714551 |
145 | MP0005266_abnormal_metabolism | 0.62931780 |
146 | MP0008438_abnormal_cutaneous_collagen | 0.62699827 |
147 | MP0005377_hearing/vestibular/ear_phenot | 0.60215070 |
148 | MP0003878_abnormal_ear_physiology | 0.60215070 |
149 | MP0003656_abnormal_erythrocyte_physiolo | 0.60087379 |
150 | MP0002210_abnormal_sex_determination | 0.59883142 |
151 | MP0002429_abnormal_blood_cell | 0.59456574 |
152 | MP0000371_diluted_coat_color | 0.56881369 |
153 | MP0003115_abnormal_respiratory_system | 0.56780349 |
154 | MP0002398_abnormal_bone_marrow | 0.56573591 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.19675598 |
2 | Reticulocytopenia (HP:0001896) | 4.09552654 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 3.96858693 |
4 | Macrocytic anemia (HP:0001972) | 3.62562622 |
5 | Breast hypoplasia (HP:0003187) | 3.54537501 |
6 | Birth length less than 3rd percentile (HP:0003561) | 3.39237268 |
7 | Multiple enchondromatosis (HP:0005701) | 3.35976637 |
8 | Oral leukoplakia (HP:0002745) | 3.35912889 |
9 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33779868 |
10 | Selective tooth agenesis (HP:0001592) | 3.18886675 |
11 | Hyperglycinemia (HP:0002154) | 3.15256890 |
12 | Megaloblastic anemia (HP:0001889) | 3.15146941 |
13 | Cholecystitis (HP:0001082) | 3.13040305 |
14 | Abnormal gallbladder physiology (HP:0012438) | 3.13040305 |
15 | Hypobetalipoproteinemia (HP:0003563) | 3.10355073 |
16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07272835 |
17 | Microretrognathia (HP:0000308) | 2.87104792 |
18 | Systemic lupus erythematosus (HP:0002725) | 2.86890020 |
19 | Carpal bone hypoplasia (HP:0001498) | 2.85400335 |
20 | Rough bone trabeculation (HP:0100670) | 2.83039578 |
21 | Joint hemorrhage (HP:0005261) | 2.82244793 |
22 | Cerebral hypomyelination (HP:0006808) | 2.77368131 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.75487486 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.75487486 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.75487486 |
26 | Colon cancer (HP:0003003) | 2.75487347 |
27 | Degeneration of anterior horn cells (HP:0002398) | 2.71897772 |
28 | Abnormality of the anterior horn cell (HP:0006802) | 2.71897772 |
29 | Trismus (HP:0000211) | 2.69601711 |
30 | Purpura (HP:0000979) | 2.67823705 |
31 | Abnormality of glycine metabolism (HP:0010895) | 2.65432236 |
32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65432236 |
33 | Type I transferrin isoform profile (HP:0003642) | 2.64281670 |
34 | Ragged-red muscle fibers (HP:0003200) | 2.64119638 |
35 | Hyperglycinuria (HP:0003108) | 2.63923587 |
36 | Recurrent abscess formation (HP:0002722) | 2.62991999 |
37 | Pallor (HP:0000980) | 2.62423904 |
38 | Xanthomatosis (HP:0000991) | 2.62398553 |
39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.60657654 |
40 | Obstructive lung disease (HP:0006536) | 2.58450093 |
41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58450093 |
42 | Hyperammonemia (HP:0001987) | 2.56707347 |
43 | Vertebral compression fractures (HP:0002953) | 2.56467746 |
44 | Abnormality of serum amino acid levels (HP:0003112) | 2.53801743 |
45 | Deep venous thrombosis (HP:0002625) | 2.50978441 |
46 | Abnormality of macrophages (HP:0004311) | 2.50886347 |
47 | Prolonged partial thromboplastin time (HP:0003645) | 2.49741733 |
48 | Hepatosplenomegaly (HP:0001433) | 2.49082565 |
49 | Increased serum ferritin (HP:0003281) | 2.47860219 |
50 | Opisthotonus (HP:0002179) | 2.46536574 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45129976 |
52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44690020 |
53 | Increased cerebral lipofuscin (HP:0011813) | 2.43293587 |
54 | Increased muscle lipid content (HP:0009058) | 2.41856698 |
55 | Agammaglobulinemia (HP:0004432) | 2.38590774 |
56 | Amyloidosis (HP:0011034) | 2.38413297 |
57 | Progressive muscle weakness (HP:0003323) | 2.38398317 |
58 | Hemorrhage of the eye (HP:0011885) | 2.38085471 |
59 | Premature ovarian failure (HP:0008209) | 2.36394881 |
60 | Vacuolated lymphocytes (HP:0001922) | 2.35499807 |
61 | Spastic diplegia (HP:0001264) | 2.33842515 |
62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33293876 |
63 | Cellulitis (HP:0100658) | 2.32922880 |
64 | Abnormality of the Achilles tendon (HP:0005109) | 2.32749912 |
65 | Aplastic anemia (HP:0001915) | 2.32739399 |
66 | Hypertensive crisis (HP:0100735) | 2.32634785 |
67 | Nonimmune hydrops fetalis (HP:0001790) | 2.32194707 |
68 | Hypolipoproteinemia (HP:0010981) | 2.32046456 |
69 | Testicular atrophy (HP:0000029) | 2.29436033 |
70 | Abnormality of reticulocytes (HP:0004312) | 2.27275734 |
71 | Secondary amenorrhea (HP:0000869) | 2.26719530 |
72 | Abnormality of complement system (HP:0005339) | 2.23058452 |
73 | Reduced antithrombin III activity (HP:0001976) | 2.22912158 |
74 | Protrusio acetabuli (HP:0003179) | 2.20971178 |
75 | Recurrent bacterial skin infections (HP:0005406) | 2.19922130 |
76 | Abnormality of the umbilical cord (HP:0010881) | 2.19593677 |
77 | Ependymoma (HP:0002888) | 2.18799911 |
78 | Patellar aplasia (HP:0006443) | 2.16500403 |
79 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.14934455 |
80 | Thrombocytosis (HP:0001894) | 2.14796130 |
81 | Intrahepatic cholestasis (HP:0001406) | 2.14576994 |
82 | Neoplasm of the pancreas (HP:0002894) | 2.14525739 |
83 | Dysostosis multiplex (HP:0000943) | 2.13521561 |
84 | Achilles tendon contracture (HP:0001771) | 2.13396702 |
85 | Nausea (HP:0002018) | 2.12982013 |
86 | Abnormality of methionine metabolism (HP:0010901) | 2.11294862 |
87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10913005 |
88 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10913005 |
89 | Abnormal protein glycosylation (HP:0012346) | 2.10913005 |
90 | Abnormal glycosylation (HP:0012345) | 2.10913005 |
91 | Impulsivity (HP:0100710) | 2.10499889 |
92 | Dicarboxylic aciduria (HP:0003215) | 2.10215869 |
93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10215869 |
94 | Abnormal cartilage morphology (HP:0002763) | 2.09381029 |
95 | Mediastinal lymphadenopathy (HP:0100721) | 2.08468928 |
96 | Petechiae (HP:0000967) | 2.05355906 |
97 | Microvesicular hepatic steatosis (HP:0001414) | 2.05019439 |
98 | Hepatocellular necrosis (HP:0001404) | 2.04864695 |
99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04693164 |
100 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03364088 |
101 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01993335 |
102 | Complement deficiency (HP:0004431) | 2.00911794 |
103 | Meningitis (HP:0001287) | 2.00013889 |
104 | Polygenic inheritance (HP:0010982) | 1.97949839 |
105 | Progressive neurologic deterioration (HP:0002344) | 1.97940888 |
106 | Absent thumb (HP:0009777) | 1.96974679 |
107 | Cholelithiasis (HP:0001081) | 1.96947866 |
108 | Eczematoid dermatitis (HP:0000976) | 1.95511821 |
109 | Lethargy (HP:0001254) | 1.95025169 |
110 | Broad distal phalanx of finger (HP:0009836) | 1.94048658 |
111 | Mitochondrial inheritance (HP:0001427) | 1.93471734 |
112 | Increased serum lactate (HP:0002151) | 1.93271533 |
113 | Abnormal trabecular bone morphology (HP:0100671) | 1.93052326 |
114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90911766 |
115 | Respiratory difficulties (HP:0002880) | 1.89654881 |
116 | Lactic acidosis (HP:0003128) | 1.89630297 |
117 | Cerebral palsy (HP:0100021) | 1.89315461 |
118 | Rhabdomyosarcoma (HP:0002859) | 1.89220361 |
119 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.87846912 |
120 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.87846912 |
121 | 11 pairs of ribs (HP:0000878) | 1.86995046 |
122 | Hypergonadotropic hypogonadism (HP:0000815) | 1.86100658 |
123 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85987086 |
124 | Poor head control (HP:0002421) | 1.85639032 |
125 | Abnormality of glycolysis (HP:0004366) | 1.85576555 |
126 | Increased serum pyruvate (HP:0003542) | 1.85576555 |
127 | Pancytopenia (HP:0001876) | 1.85277348 |
128 | Premature graying of hair (HP:0002216) | 1.84967711 |
129 | Colitis (HP:0002583) | 1.83801870 |
130 | Absent radius (HP:0003974) | 1.83227090 |
131 | Squamous cell carcinoma (HP:0002860) | 1.83118568 |
132 | Hypoalphalipoproteinemia (HP:0003233) | 1.82187860 |
133 | Hypertriglyceridemia (HP:0002155) | 1.81900006 |
134 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.81391518 |
135 | Single umbilical artery (HP:0001195) | 1.81391518 |
136 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.81391518 |
137 | Sparse eyelashes (HP:0000653) | 1.81134370 |
138 | Medulloblastoma (HP:0002885) | 1.80961984 |
139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80162688 |
140 | Hyperlipoproteinemia (HP:0010980) | 1.79154000 |
141 | Renal Fanconi syndrome (HP:0001994) | 1.78983856 |
142 | Abnormality of iron homeostasis (HP:0011031) | 1.78932392 |
143 | Increased CSF lactate (HP:0002490) | 1.78891269 |
144 | Entropion (HP:0000621) | 1.78468003 |
145 | Myositis (HP:0100614) | 1.78115326 |
146 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.78098512 |
147 | Hypokinesia (HP:0002375) | 1.77310571 |
148 | Spastic paraparesis (HP:0002313) | 1.75739555 |
149 | Personality changes (HP:0000751) | 1.75129323 |
150 | Cellular immunodeficiency (HP:0005374) | 1.74656022 |
151 | J-shaped sella turcica (HP:0002680) | 1.74232488 |
152 | CNS demyelination (HP:0007305) | 1.73947458 |
153 | Stridor (HP:0010307) | 1.73895202 |
154 | Basal cell carcinoma (HP:0002671) | 1.72985454 |
155 | Recurrent viral infections (HP:0004429) | 1.72914789 |
156 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72876064 |
157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72876064 |
158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72876064 |
159 | Increased IgM level (HP:0003496) | 1.72845291 |
160 | Meckel diverticulum (HP:0002245) | 1.72378187 |
161 | Acute encephalopathy (HP:0006846) | 1.71727232 |
162 | Angiofibromas (HP:0010615) | 1.71600156 |
163 | Adenoma sebaceum (HP:0009720) | 1.71600156 |
164 | Rhabdomyolysis (HP:0003201) | 1.71508558 |
165 | Delayed CNS myelination (HP:0002188) | 1.71181509 |
166 | Abnormality of T cell physiology (HP:0011840) | 1.70724911 |
167 | Hypoglycemic coma (HP:0001325) | 1.69961382 |
168 | Agnosia (HP:0010524) | 1.69898360 |
169 | Abnormality of nucleobase metabolism (HP:0010932) | 1.68718703 |
170 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68224182 |
171 | Horseshoe kidney (HP:0000085) | 1.68187094 |
172 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.66652347 |
173 | Aplasia involving forearm bones (HP:0009822) | 1.65792785 |
174 | Absent forearm bone (HP:0003953) | 1.65792785 |
175 | Hepatic necrosis (HP:0002605) | 1.65774746 |
176 | Ureteral duplication (HP:0000073) | 1.64964652 |
177 | Gout (HP:0001997) | 1.64024099 |
178 | Bone marrow hypocellularity (HP:0005528) | 1.62773565 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 4.81436804 |
2 | WEE1 | 4.13814225 |
3 | VRK2 | 4.09499342 |
4 | SMG1 | 3.15240255 |
5 | NME2 | 3.08477115 |
6 | EIF2AK1 | 2.80493247 |
7 | EPHA2 | 2.55869718 |
8 | BCKDK | 2.54767676 |
9 | CDC7 | 2.48833943 |
10 | NEK2 | 2.35416816 |
11 | STK16 | 2.27104637 |
12 | TESK2 | 2.18224275 |
13 | PLK4 | 2.14646916 |
14 | TSSK6 | 2.02080741 |
15 | TTK | 2.01667009 |
16 | PKN2 | 2.01637652 |
17 | NEK1 | 2.01087320 |
18 | SCYL2 | 1.97351117 |
19 | RPS6KB2 | 1.94051518 |
20 | EEF2K | 1.83434206 |
21 | TLK1 | 1.79959311 |
22 | KDR | 1.71528597 |
23 | TRIB3 | 1.66202905 |
24 | ACVR1B | 1.63733429 |
25 | EIF2AK3 | 1.57727013 |
26 | SRPK1 | 1.56673411 |
27 | MAP3K11 | 1.54197532 |
28 | PLK1 | 1.53962285 |
29 | MAP3K8 | 1.50528358 |
30 | TBK1 | 1.49496944 |
31 | BRSK2 | 1.48546924 |
32 | PAK4 | 1.43231223 |
33 | CDK7 | 1.41832551 |
34 | MAP3K10 | 1.39432577 |
35 | CDK4 | 1.39056576 |
36 | RPS6KA4 | 1.36302373 |
37 | PIM2 | 1.35125953 |
38 | DYRK3 | 1.34360208 |
39 | PDK2 | 1.33796763 |
40 | AURKB | 1.33559014 |
41 | LRRK2 | 1.29393339 |
42 | FLT3 | 1.27850434 |
43 | DAPK1 | 1.22275688 |
44 | AURKA | 1.20951156 |
45 | LIMK1 | 1.19706093 |
46 | IRAK4 | 1.14199128 |
47 | MAP2K3 | 1.13182750 |
48 | PASK | 1.11877043 |
49 | SIK1 | 1.07049755 |
50 | STK10 | 1.06476978 |
51 | ATR | 1.05889569 |
52 | VRK1 | 1.05295333 |
53 | MUSK | 1.05235208 |
54 | MAP4K1 | 1.04553434 |
55 | ERN1 | 1.01397408 |
56 | TGFBR1 | 0.99706809 |
57 | ZAK | 0.99566369 |
58 | PRKD3 | 0.97611635 |
59 | CHEK2 | 0.95808219 |
60 | BRSK1 | 0.95707533 |
61 | PRPF4B | 0.91993430 |
62 | PLK3 | 0.90347566 |
63 | MKNK1 | 0.85100350 |
64 | TESK1 | 0.84659596 |
65 | ICK | 0.83546735 |
66 | PAK1 | 0.82756862 |
67 | PBK | 0.82483526 |
68 | TAOK2 | 0.82225477 |
69 | PIM1 | 0.80715154 |
70 | MARK3 | 0.80204176 |
71 | IKBKB | 0.78534874 |
72 | CHEK1 | 0.77643572 |
73 | IRAK3 | 0.77239109 |
74 | MAP2K2 | 0.76697204 |
75 | BRAF | 0.75982169 |
76 | MAP3K3 | 0.75420280 |
77 | STK4 | 0.73725623 |
78 | PRKCI | 0.70856204 |
79 | ILK | 0.69938142 |
80 | MAPKAPK3 | 0.69119245 |
81 | GRK6 | 0.66144124 |
82 | TNK2 | 0.65275505 |
83 | CSNK1G3 | 0.64761333 |
84 | LATS2 | 0.64225750 |
85 | PDPK1 | 0.63043092 |
86 | ABL2 | 0.62321377 |
87 | IKBKE | 0.60760994 |
88 | IRAK2 | 0.59692778 |
89 | CSF1R | 0.59582178 |
90 | CSNK2A2 | 0.59104006 |
91 | TAF1 | 0.57746939 |
92 | ZAP70 | 0.57549421 |
93 | CSNK2A1 | 0.57446039 |
94 | FES | 0.56353911 |
95 | CDK19 | 0.55366071 |
96 | CDK2 | 0.55101136 |
97 | NEK9 | 0.54992824 |
98 | JAK3 | 0.54497078 |
99 | AKT2 | 0.52918230 |
100 | MAP3K1 | 0.50008374 |
101 | PRKD2 | 0.49087585 |
102 | CDK6 | 0.49073361 |
103 | MATK | 0.48897535 |
104 | MTOR | 0.47923605 |
105 | NME1 | 0.46966286 |
106 | PAK2 | 0.46498878 |
107 | BLK | 0.45758066 |
108 | ALK | 0.45177736 |
109 | MAPKAPK2 | 0.45040271 |
110 | FGFR4 | 0.43336217 |
111 | CSNK1A1L | 0.42812650 |
112 | STK38L | 0.42151368 |
113 | KIT | 0.41537728 |
114 | RPS6KC1 | 0.41168505 |
115 | RPS6KL1 | 0.41168505 |
116 | CDK12 | 0.40546385 |
117 | CDK9 | 0.39812096 |
118 | DAPK3 | 0.39382380 |
119 | MAPK11 | 0.38871192 |
120 | RPS6KA2 | 0.38596771 |
121 | MKNK2 | 0.38002950 |
122 | ATM | 0.37896685 |
123 | ARAF | 0.37002018 |
124 | TIE1 | 0.36652156 |
125 | LMTK2 | 0.36599208 |
126 | RPS6KA5 | 0.34779050 |
127 | PRKG2 | 0.34253848 |
128 | STK3 | 0.33395752 |
129 | BTK | 0.32810935 |
130 | PDK1 | 0.32323126 |
131 | BMX | 0.32274462 |
132 | RPS6KA6 | 0.32159783 |
133 | PTK6 | 0.31066153 |
134 | CDK8 | 0.28621929 |
135 | TYK2 | 0.28487142 |
136 | PDK3 | 0.28297104 |
137 | PDK4 | 0.28297104 |
138 | CDK1 | 0.27601769 |
139 | CCNB1 | 0.27534136 |
140 | CSNK1E | 0.26817448 |
141 | FGFR1 | 0.26022022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.96530956 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.54880023 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.18697159 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 3.10183179 |
5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.83120180 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.72823763 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.51449137 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37560404 |
9 | Spliceosome_Homo sapiens_hsa03040 | 2.36380298 |
10 | Base excision repair_Homo sapiens_hsa03410 | 2.34983968 |
11 | RNA transport_Homo sapiens_hsa03013 | 2.30246581 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.20272796 |
13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.16057705 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10226145 |
15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.06637737 |
16 | Homologous recombination_Homo sapiens_hsa03440 | 1.99484065 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90061214 |
18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86036887 |
19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.79293332 |
20 | Cell cycle_Homo sapiens_hsa04110 | 1.71786668 |
21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.67537681 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63737479 |
23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.62543099 |
24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.61832827 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60660629 |
26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60255867 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54778280 |
28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52918323 |
29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51993907 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50249844 |
31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42896234 |
32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41967897 |
33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34467244 |
34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23691751 |
35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23146278 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20747419 |
37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17426245 |
38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15791076 |
39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14639897 |
40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08298530 |
41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03798249 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03145871 |
43 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01355721 |
44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00872060 |
45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00747671 |
46 | RNA degradation_Homo sapiens_hsa03018 | 1.00445195 |
47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00362506 |
48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00260435 |
49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99276398 |
50 | Lysosome_Homo sapiens_hsa04142 | 0.97546481 |
51 | Purine metabolism_Homo sapiens_hsa00230 | 0.97541528 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94534426 |
53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92818782 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92163157 |
55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92124848 |
56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90756862 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88555609 |
58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86855554 |
59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83502057 |
60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83460330 |
61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81955676 |
62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79375179 |
63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76233473 |
64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75883997 |
65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72336940 |
66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72336148 |
67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70703104 |
68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69995817 |
69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68807909 |
70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68707166 |
71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67861976 |
72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67230934 |
73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66653384 |
74 | Peroxisome_Homo sapiens_hsa04146 | 0.63708502 |
75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63573776 |
76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63211197 |
77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62249205 |
78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60684474 |
79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57318891 |
80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56471283 |
81 | Shigellosis_Homo sapiens_hsa05131 | 0.55602778 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54016090 |
83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53871811 |
84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53227928 |
85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53224509 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52250661 |
87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51501398 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51468130 |
89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51124840 |
90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50918860 |
91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50323790 |
92 | Allograft rejection_Homo sapiens_hsa05330 | 0.48952146 |
93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47741438 |
94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46870927 |
95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46755566 |
96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46212208 |
97 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.45896150 |
98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45623323 |
99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44724248 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.44525462 |
101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43741409 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.41964084 |
103 | Pertussis_Homo sapiens_hsa05133 | 0.40595904 |
104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39631721 |
105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39533679 |
106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38633960 |
107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37889719 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37792121 |
109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37739852 |
110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37044109 |
111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36343611 |
112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36186303 |
113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35489073 |
114 | Protein export_Homo sapiens_hsa03060 | 0.35338867 |
115 | Bladder cancer_Homo sapiens_hsa05219 | 0.35235825 |
116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35182773 |
117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34289884 |
118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33626466 |
119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33510659 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31141503 |
121 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30575770 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.29083971 |
123 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28972762 |
124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27445054 |
125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27400781 |
126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27239211 |
127 | Lysine degradation_Homo sapiens_hsa00310 | 0.26638058 |
128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26079857 |